94 related articles for article (PubMed ID: 3602910)
1. [Determination of the concentrations of niflumic acid in the plasma and synovial tissue following repeated administration of capsules].
Dorfmann H; Gendron A; Duchenne P
Rev Rhum Mal Osteoartic; 1987 Apr; 54(4):339-41. PubMed ID: 3602910
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and availability of niflumic acid in humans.
Houin G; Tremblay D; Bree F; Dufour A; Ledudal P; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):130-4. PubMed ID: 6852999
[TBL] [Abstract][Full Text] [Related]
3. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
4. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.
Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K
NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358
[TBL] [Abstract][Full Text] [Related]
5. [Plasma and tissue concentrations of biphenylacetic acid following 1 week oral fenbufen medication and topical administration of Felbinac gel on the knee joint].
Bolten W; Salzmann G; Goldmann R; Miehlke K
Z Rheumatol; 1989; 48(6):317-22. PubMed ID: 2696292
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of morniflumate and its major active metabolite, niflumic acid, in human plasma by high-performance liquid chromatography in stability and pharmacokinetic studies.
Cho HY; Park GK; Lee YB
Biomed Chromatogr; 2013 Nov; 27(11):1438-43. PubMed ID: 23722315
[TBL] [Abstract][Full Text] [Related]
7. [Ionized fluorine in the plasma and urine of subjects treated with organofluorine drugs prescribed in rheumatology].
Boiteau HL; Prost A; Rossel-Renac F; Audran M; Hamelin JP; Carlier N
Rev Rhum Mal Osteoartic; 1979 Feb; 46(2):123-32. PubMed ID: 34870
[TBL] [Abstract][Full Text] [Related]
8. [Change in the plasma and urine levels of ionized fluorine under the influence of low doses of niflumic acid. Possible application to the treatment of osteoporosis].
Prost A; Boiteau HL; Rossel-Renac F; Audran M; Caumon JP
Rev Rhum Mal Osteoartic; 1980 Nov; 47(11):635-43. PubMed ID: 7444306
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Gaganis P; Miners JO; Knights KM
Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
[TBL] [Abstract][Full Text] [Related]
10. [Non-steroidal anti-inflammatory agents and pregnancy. A study of renal and digestive toxicity of niflumic acid in the perinatal period].
Alessandri JL; Abossolo T; Reynaud I; Montbrun A; Sommer JC; Tilmont P
J Gynecol Obstet Biol Reprod (Paris); 1994; 23(7):813-8. PubMed ID: 7822716
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration.
Dominkus M; Nicolakis M; Kotz R; Wilkinson FE; Kaiser RR; Chlud K
Arzneimittelforschung; 1996 Dec; 46(12):1138-43. PubMed ID: 9006788
[TBL] [Abstract][Full Text] [Related]
12. [Comparative test of the anti-inflammatory effect of niflumic acid by rectal administration in children].
Sentilhes C; Delon R
Rev Odontostomatol (Paris); 1976; 5(6):491-4. PubMed ID: 1071232
[No Abstract] [Full Text] [Related]
13. [Rhabdomyolysis and niflumic acid].
Desvignes V; Fialip J; Palcoux JB; Lavarenne J
Therapie; 1988; 43(5):429-30. PubMed ID: 3067420
[No Abstract] [Full Text] [Related]
14. Contribution of pH to systemic exposure of niflumic acid following oral administration of talniflumate.
Kim E; Kang W
Eur J Clin Pharmacol; 2011 Apr; 67(4):425-428. PubMed ID: 21327911
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
16. [Effects of a niflumic acid derivative in tonsil surgery in children - controlled study].
Lacomme Y; Pessey JJ
Rev Laryngol Otol Rhinol (Bord); 1978; 99(1-2):159-63. PubMed ID: 353942
[No Abstract] [Full Text] [Related]
17. [Lithium poisoning. 2 unpublished interactions: acetazolamide and niflumic acid].
Gay C; Plas J; Granger B; Olié JP; Lôo H
Encephale; 1985; 11(6):261-2. PubMed ID: 3830693
[TBL] [Abstract][Full Text] [Related]
18. [Cannabis and Nifluril: reply].
Léquippe V
Ann Biol Clin (Paris); 2003; 61(1):121. PubMed ID: 12611373
[No Abstract] [Full Text] [Related]
19. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
Raffaetà G; Saponati G; Terzuoli A
G Clin Med; 1987 Oct; 68(10):507-13. PubMed ID: 3428515
[No Abstract] [Full Text] [Related]
20. [Fluorometric determination of plasma niflumic acid by direct estimation of thin layer chromatograms].
Schumacher A; Geissler HE; Mutschler E
J Chromatogr; 1979 Mar; 162(3):489-93. PubMed ID: 528619
[No Abstract] [Full Text] [Related]
[Next] [New Search]
